Incyte today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal ...
JPMorgan Chase & Co. ( JPM) Goldman Sachs 2025 U.S. Financial Services Conference December 9, 2025 12:20 PM EST ...
SSR Mining delivers strong production, solid margins, cash strength and asset growth with leverage to precious metals and ...
Minnesota’s nutrition fraud exposes structural and psychological vulnerabilities within federal programs and Obamacare’s ...
An AI image generator startup’s database was left accessible to the open internet, revealing more than 1 million images and ...
For numerous fundamental processes of life, the formation of certain protein patterns is essential. Protein pattern formation ...
Global privacy regulations, the death of the third-party cookie, ad-blocking: marketers have entered a new era of data privacy. The future of marketing is going to look very different from what the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback